NCT03018418View on ClinicalTrials.gov

Proton Therapy in Reducing Toxicity in Anal Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 4, 2017

Primary Completion Date

April 7, 2022

Study Completion Date

July 1, 2025

Conditions
Anus Neoplasms
Interventions
RADIATION

Proton therapy

Primary target volume 50.4-54 CGE in 28-30 fractions; Nodal volumes 42-54 CGE in 28-30 fractions

DRUG

Chemotherapy

5FU 1000 mg/m2/day as 96 hour infusion days 1-5 and 29-33; Mitomycin 10mg/m2 days 1 and 29

Trial Locations (1)

45044

UC Health, Cincinnati

All Listed Sponsors
lead

Jordan Kharofa

OTHER